This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kashiwagi, K Articles by Tsukahara, S Search for Related Content PubMed PubMed Citation Articles by Kashiwagi, K Articles by Tsukahara, S Topic Collections Relevant Article

Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost

University of Yamanashi Faculty of Medicine, Tamaho Yamanashi, Japan

Correspondence to:
Correspondence to:
Kenji Kashiwagi, MD, Department of Ophthalmology, Yamanashi Medical University, 1110 Shimokato, Tamaho, Yamanashi 409-3898, Japan;
kenjik{at}res.yamanashi-med.ac.jp

Aim: To investigate the effects of a non-steroidal anti-inflammatory drug (NSAID) ophthalmic solution on latanoprost induced intraocular pressure (IOP) reduction using normal volunteers.

Methods: This study was conducted as a prospective and observer masked clinical trial. 13 normal volunteers were enrolled. After measurement of basal IOP and ophthalmic examination, latanoprost ophthalmic solution was initially administered to both eyes once daily. Four weeks later, an NSAID ophthalmic solution, sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate (refer to bromfenac sodium hydrate), was co-administered to one randomly selected eye (NSAID group) twice daily for 2 weeks. The other eye was employed as a control (non-NSAID group). After withdrawal of the NSAID ophthalmic solution, latanoprost ophthalmic solution was continuously administered for another 2 weeks and was then withdrawn. After a 4 week washout, only bromfenac sodium hydrate ophthalmic solution was administered to the eyes of the NSAID group for 2 weeks. During the study period, ophthalmic examination, including IOP measurement was performed in an observer masked fashion.

Results: Before initiation of bromfenac sodium hydrate, baseline IOPs of the non-NSAID group and the NSAID group were 15.73 (SD 1.97) mm Hg and 15.86 (2.06) mm Hg, respectively (p=0.88). Although latanoprost ophthalmic solution significantly reduced IOP in both groups, co-administration of bromfenac sodium hydrate significantly inhibited latanoprost induced IOP reduction compared with the non-NSAID group. The IOPs of the non-NSAID and NSAID groups were 10.18 (1.17) mm Hg and 11.63 (1.35) mm Hg with a 2 week co-administration, respectively (p <0.01). Withdrawal of bromfenac sodium hydrate ophthalmic solution diminished the difference between the two groups. Re-administration of bromfenac sodium ophthalmic solution only did not affect IOP.

Conclusion: These results indicate that NSAID ophthalmic solution may interfere with IOP reduction by latanoprost ophthalmic solution in normal volunteers and that we should take this into account when treating patients with glaucoma using latanoprost ophthalmic solution.

Keywords: latanoprost; non-steroidal anti-inflammatory drugs; intraocular pressure; glaucoma; drug interaction

Relevant Article

BJO at a glance

Creig Hoyt
Br. J. Ophthalmol. 2003 87: 253. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				T. Ota, M. Aihara, T. Saeki, S. Narumiya, and M. Araie The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice Br. J. Ophthalmol., May 1, 2007; 91(5): 673 - 676. [Abstract] [Full Text] [PDF]

				T. Ota, M. Aihara, T. Saeki, S. Narumiya, and M. Araie The Effects of Prostaglandin Analogues on Prostanoid EP1, EP2, and EP3 Receptor-Deficient Mice. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3395 - 3399. [Abstract] [Full Text] [PDF]

				A Alm Can NSAIDs and prostaglandin analogues be combined? Br. J. Ophthalmol., March 1, 2006; 90(3): 259 - 260. [Full Text] [PDF]

				T Chiba, K Kashiwagi, N Chiba, and S Tsukahara Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension. Br. J. Ophthalmol., March 1, 2006; 90(3): 314 - 317. [Abstract] [Full Text] [PDF]